Fernando Vargas-Ursúa

Sotatercept as a Treatment for Pulmonary Hypertension Associated With Connective Tissue Disease and ILD

Sotatercept is a drug approved for pulmonary arterial hypertension (PAH) that improves mortality, right ventricular function, functional class, NT-proBNP, and 6-minute walk distance. However, no clinical trials support its use in patients with pulmonary hypertension (PH) and interstitial lung disease (ILD), and respira...